DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Granger CB, Lopes RD, Hanna M. et al.
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Am Heart J 2015;
169 (01) 25-30
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.